Viewing entries tagged with 'disease-modifying drugs'

Multiple Sclerosis (MS) is an inflammatory disease in which a person’s immune system attacks their central nervous system. It most commonly affects young people, with an average age at diagnosis of just 30 years. There is no cure, and it can cause progressive neurological deterioration, affecting mobility, vision and sometimes cognition. About 20,000 Australians have MS.